In 2017, with funding from CIHR’s Partnership for Health Systems Improvement initiative, we established the Canadian Real-World Evidence for Value of Cancer Drug (CanREValue) project t
BACKGROUND: New therapeutics are urgently needed to improve the outcome of men with castrate-resistant prostate cancer (mCRPC), a leading cause of cancer-relat
Due to the site of the cancer, head and neck cancer (HNCa) survivors face unique challenges and serious h
Oral cancer is an important global health problem. The disease has a high mortality rate (~63% 5-year survival) mainly due to the advanced stage at which it i
At the core of the BC OCPP is the
Objective: Evaluation of the long term protection of primary HPV testing for cervix screening in a large cohort of BC women
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.